We are live on ! Find out more
ACAD icon

Acadia Pharmaceuticals

245 hedge funds and large institutions have $2.12B invested in Acadia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 88 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $25.3M | Put options by funds: $17.4M

2.22% more ownership

Funds ownership: 91.24%93.46% (+2.2%)

6% less funds holding

Funds holding: 262245 (-17)

22% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 88

23% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 47

40% less capital invested

Capital invested by funds: $3.56B → $2.12B (-$1.44B)

67% less funds holding in top 10

Funds holding in top 10: 62 (-4)

Holders
245
Holders Change
-17
Holders Change %
-6.49%
% of All Funds
4.13%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
36
Increased
69
Reduced
88
Closed
47
Calls
$25.3M
Puts
$17.4M
Net Calls
+$7.88M
Net Calls Change
-$10.4M